Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune hyroid disease

European Journal of Endocrinology

Volumn 176, Issue 2, 2017, Pages 253-265

  Nazarpour, Sima ^a,c   Tehrani, Fahimeh Ramezani ^b   Simbar, Masoumeh ^c   Tohidi, Maryam ^d   Majd, Hamid Alavi ^e   Azizi, Fereidoun ^f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Department of Biostatistics   (Iran)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN; AUTOANTIBODY; IODIDE PEROXIDASE; THYROID MICROSOMAL ANTIBODIES;

ADULT; ADVERSE OUTCOME; ARTICLE; AUTOIMMUNE THYROIDITIS; BIRTH WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FREE THYROXINE INDEX; GESTATION PERIOD; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HOSPITAL ADMISSION; HUMAN; HYPOTHYROIDISM; MORNING DOSAGE; NORMAL HUMAN; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STILLBIRTH; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THIRD TRIMESTER PREGNANCY; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; MAJOR CLINICAL STUDY; PRENATAL CARE; BLOOD; IMMUNOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; THYROIDITIS, AUTOIMMUNE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; IODIDE PEROXIDASE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; THYROIDITIS, AUTOIMMUNE; THYROXINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85009151544     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-16-0548     Document Type: Article

References (61)

1. Chen L & Hu R. Thyroid autoimmunity and miscarriage: a metaanalysis. Clinical Endocrinology 2011 74 513-519. (doi:10.1111/j.1365-2265.2010.03974.x)
2. Cignini P, Cafa EV, Giorlandino C, Capriglione S, Spata A & Dugo N. Thyroid physiology and common diseases in pregnancy: review of literature. Journal of Perinatal Medicine 2012 6 64-71
3. Mannisto T, Mendola P, Grewal J, Xie Y, Chen Z & Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. Journal of Clinical Endocrinology and Metabolism 2013 98 2725-2733. (doi:10.1210/jc.2012-4233)
4. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ & Cunningham FG. Subclinical hypothyroidism and pregnancy outcomes. Obstetrics and Gynecology 2005 105 239-245. (doi:10.1097/01.AOG.0000152345.99421.22)
5. Glinoer D, Riahi M, Grun JP & Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. Journal of Clinical Endocrinology and Metabolism 1994 79 197-204. (doi:10.1210/jcem.79.1. 8027226)
6. Karakosta P, Alegakis D, Georgiou V, Roumeliotaki T, Fthenou E, Vassilaki M, Boumpas D, Castanas E, Kogevinas M & Chatzi L. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. Journal of Clinical Endocrinology and Metabolism 2012. 4464-4472. (doi:10.1210/jc.2012-2540)
7. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T & Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. Journal of Clinical Endocrinology and Metabolism 2011 96 E920-E924. (doi:10.1210/jc.2011-0026)
8. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, Luthy D, Gross S, Bianchi DW & D'Alton ME. Maternal thyroid hypofunction and pregnancy outcome. Obstetrics and Gynecology 2008 112 85-92. (doi:10.1097/ AOG.0b013e3181788dd7)
9. Muller AF, Verhoeff A, Mantel MJ & Berghout A. Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Fertility and Sterility 1999 71 30-34. (doi:10.1016/S0015-0282(98)00394-X)
10. Chan S & Boelaert K. Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. Clinical Endocrinology (Review) 2015.313-326. (doi:10.1111/cen.12605)
11. Sheehan PM, Nankervis A, Araujo Junior E & Da Silva Costa F. Maternal thyroid disease and preterm birth: systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism (Meta-AnalysisReview) 2015 100 4325-4331. (doi:10.1210/jc.2015-3074)
12. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG & Bonsel GJ. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. European Journal of Endocrinology 2009 160 985-991. (doi:10.1530/EJE-08-0953)
13. Stagnaro-Green A. Thyroid antibodies and miscarriage: where are we at a generation later? Journal of Thyroid Research 2011 2011 841949. (doi:10.4061/2011/841949)
14. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J & Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011 342 d2616. (doi:10.1136/bmj.d2616)
15. Ashoor G, Rotas M, Maiz N, Kametas NA & Nicolaides KH. Maternal thyroid function at 11-13 weeks of gestation in women with hypothyroidism treated by thyroxine. Fetal Diagnosis and Therapy 2010 28 22-27. (doi:10.1159/000314906)
16. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, Hofman A, Ross HA, Hooijkaas H, Tiemeier H et al. Hypothyroxinemia and TPOantibody positivity are risk factors for premature delivery: the generation R study. Journal of Clinical Endocrinology and Metabolism (Research Support, Non-U.S. Govt) 2013 98 4382-4390. (doi:10.1210/jc.2013-2855)
17. Lata K, Dutta P, Sridhar S, Rohilla M, Srinivasan A, Prashad GR, Shah VN & Bhansali A. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case-control study. Endocrine Connections 2013 2 118-124. (doi:10.1530/ EC-13-0012)
18. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D & Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. Journal of Clinical Endocrinology and Metabolism 2006 91 2587-2591. (doi:10.1210/jc.2005-1603)
19. Negro R, Mangieri T, Coppola L, Presicce G, Casavola EC, Gismondi R, Locorotondo G, Caroli P, Pezzarossa A, Dazzi D et al. Levothyroxine treatment in thyroid peroxidase antibodypositive women undergoing assisted reproduction technologies: a prospective study. Human Reproduction 2005 20 1529-1533. (doi:10.1093/humrep/deh843)
20. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011 21 1081-1125. (doi:10.1089/thy.2011.0087)
21. Azizi F, Mehran L, Amouzegar A, Delshad H, Tohidi M, Askari S & Hedayati M. Establishment of the trimester-specific reference range for free thyroxine index. Thyroid 2013 23 354-359. (doi:10.1089/ thy.2012.0407)
22. ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination (A Guide for Programme Managers). World Health Organization, 2007
23. Baron RM & Kenny DA. The moderator mediator variable distinction in social psychological-research - conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 1986 51 1173-1182. (doi:10.1037/0022-3514.51.6.1173)
24. He X, Wang P, Wang Z, Xu D & Wang B. Thyroid antibodies and risk of preterm delivery: a meta-analysis of prospective cohort studies. European Journal of Endocrinology 2012 167 455-464. (doi:10.1530/ EJE-12-0379)
25. Pearce EN, Oken E, Gillman MW, Lee SL, Magnani B, Platek D & Braverman LE. Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use. Endocrine Practices (Multicenter StudyResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Govt) 2008. 33-39. (doi:10.4158/EP.14.1.33)
26. Banerjee S. Thyroid disorders in pregnancy. Journal of the Association of Physicians of India 2011 59 (Supplement) 32-34
27. Krassas GE, Poppe K & Glinoer D. Thyroid function and human reproductive health. Endocrine Reviews 2010 31 702-755. (doi:10.1210/er.2009-0041)
28. Prummel MF & Wiersinga WM. Thyroid autoimmunity and miscarriage. European Journal of Endocrinology 2004 150 751-755. (doi:10.1530/eje.0.1500751)
29. Kim NY, Cho HJ, Kim HY, Yang KM, Ahn HK, Thornton S, Park JC, Beaman K, Gilman-Sachs A & Kwak-Kim J. Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures. American Journal of Reproductive Immunology 2011 65 78-87. (doi:10.1111/j.1600-0897.2010.00911.x)
30. Alexander EK. Autoimmunity: thyroid autoantibodies and pregnancy risk. Nature Reviews Endocrinology 2011 7 501-502. (doi:10.1038/ nrendo.2011.116)
31. Gleicher N, Barad D & Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmunity Reviews 2007 7 42-45. (doi:10.1016/j.autrev.2007.06.001)
32. Kyrklund-Blomberg NB & Cnattingius S. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. American Journal of Obstetrics and Gynecology 1998 179 1051-1055. (doi:10.1016/S0002-9378(98)70214-5)
33. Nakamura H, Usa T, Motomura M, Ichikawa T, Nakao K, Kawasaki E, Tanaka M, Ishikawa K & Eguchi K. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. Journal of Endocrinological Investigation 2008 31 861-865. (doi:10.1007/ BF03346432)
34. Scofield RH. Autoantibodies as predictors of disease. Lancet 2004 363 1544-1546.(doi:10.1016/S0140-6736(04)16154-0)
35. Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanisms. Nature Reviews Endocrinology 2010 6 311-318. (doi:10.1038/nrendo.2010.46)
36. Bizzaro G & Shoenfeld Y. Vitamin D and autoimmune thyroid diseases: facts and unresolved questions. Immunologic Research (Review) 2015 61 46-52. (doi:10.1007/s12026-014-8579-z)
37. Twig G, Shina A, Amital H & Shoenfeld Y. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. Journal of Autoimmunity (Review) 2012 38 J275-J281. (doi:10.1016/j. jaut.2011.11.014)
38. Kumru P, Erdogdu E, Arisoy R, Demirci O, Ozkoral A, Ardic C, Ertekin AA, Erdogan S & Ozdemir NN. Effect of thyroid dysfunction and autoimmunity on pregnancy outcomes in low risk population. Archives of Gynecology and Obstetrics 2015 291 1047-1054. (doi:10.1007/s00404-014-3533-9)
39. Saki F, Dabbaghmanesh MH, Ghaemi SZ, Forouhari S, Omrani GR & Bakhshayeshkaram M. Thyroid autoimmunity in pregnancy and its influences on maternal and fetal outcome in Iran (a prospective study). Endocrine Research 2015 40 139-145. (doi:10.3109/07435800.2 014.966384)
40. Stagnaro-Green A. Maternal thyroid disease and preterm delivery. Journal of Clinical Endocrinology and Metabolism 2009 94 21-25. (doi:10.1210/jc.2008-1288)
41. Tierney K, Delpachitra P, Grossmann M, Onwude J, Sikaris K, Wallace EM, Hamilton EJ & Tong S. Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestation. Clinical Endocrinology 2009 71 892-895. (doi:10.1111/j.1365-2265.2009.03569.x)
42. van den Boogaard E, Vissenberg R, Land JA, van Wely M, van der Post JA, Goddijn M & Bisschop PH. Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Human Reproduction Update 2011 17 605-619. (doi:10.1093/humupd/ dmr024)
43. Abbassi-Ghanavati M, Casey BM, Spong CY, McIntire DD, Halvorson LM & Cunningham FG. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstetrics and Gynecology 2010 116 381-386. (doi:10.1097/AOG.0b013e3181e904e5)
44. Lee YL, Ng HP, Lau KS, Liu WM, O WS, Yeung WS & Kung AW. Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertility and Sterility (Research Support, Non-U.S. Govt) 2009 91 (Supplement 5) 2104-2109. (doi:10.1016/j. fertnstert.2008.07.1704)
45. Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Tarlatzis BC & Papadimas I. Thyroid autoimmunity and miscarriages: the corpus luteum hypothesis. Medical Hypotheses 2009 73 1060-1062. (doi:10.1016/j.mehy.2009.05.012)
46. Triggianese P, Perricone C, Conigliaro P, Chimenti MS, Perricone R & De Carolis C. Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure. International Journal of Immunopathology and Pharmacology 2016 29 65-75. (doi:10.1177/0394632015615130)
47. Bagis T, Gokcel A & Saygili ES. Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid 2001 11 1049-1053. (doi:10.1089/10507250175327 1743)
48. Ghafoor F, Mansoor M, Malik T, Malik MS, Khan AU, Edwards R & Akhtar W. Role of thyroid peroxidase antibodies in the outcome of pregnancy. Journal of the College of Physicians and Surgeons Pakistan 2006 16 468-471. (doi:7.2006/JCPSP.468471)
49. Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, Kinthaert J, Robijn C, Grun JP & de Nayer P. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. Journal of Clinical Endocrinology and Metabolism 1991 73 421-427. (doi:10.1210/jcem-73-2-421)
50. Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y & Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstetrics and Gynecology 1997 90 364-369. (doi:10.1016/S0029-7844(97)00283-4)
51. Liu H, Shan Z, Li C, Mao J, Xie X, Wang W, Fan C, Wang H, Zhang H, Han C et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid 2014 24 1642-1649. (doi:10.1089/ thy.2014.0029)
52. Marai I, Carp H, Shai S, Shabo R, Fishman G & Shoenfeld Y. Autoantibody panel screening in recurrent miscarriages. American Journal of Reproductive Immunology 2004 51 235-240. (doi:10.1111/ j.1600-0897.2004.00153.x)
53. Nambiar V, Jagtap VS, Sarathi V, Lila AR, Kamalanathan S, Bandgar TR, Menon PS & Shah NS. Prevalence and impact of thyroid disorders on maternal outcome in asian-Indian pregnant women. Journal of Thyroid Research 2011 2011 429097. (doi:10.4061/2011/429097)
54. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M & Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990 264 1422-1425. (doi:10.1001/ jama.1990.03450110068029)
55. Krassas GE, Perros P & Kaprara A. Thyroid autoimmunity, infertility and miscarriage. Expert Review of Endocrinology and Metabolism 2008 3 127-136. (doi:10.1586/17446651.3.2.127)
56. Kutteh WH, Yetman DL, Carr AC, Beck LA & Scott RT Jr. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertility and Sterility 1999 71 843-848. (doi:10.1016/ S0015-0282(99)00091-6)
57. Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N & Regan L. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Human Reproduction 2000 15 1637-1639. (doi:10.1093/humrep/15.7.1637)
58. Azizi F, Mehran L, Sheikholeslam R, Ordookhani A, Naghavi M, Hedayati M, Padyab M & Mirmiran P. Sustainability of awell-monitored salt iodization program in Iran: marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt. Journal of Endocrinological Investigation 2008 31 422-431. (doi:10.1007/ BF03346386)
59. Medici M, Korevaar TI, Visser WE, Visser TJ & Peeters RP. Thyroid function in pregnancy: what is normal? Clinical Chemistry 2015 61 704-713. (doi:10.1373/clinchem.2014.236646)
60. Negro R, Schwartz A & Stagnaro-Green A. Impact of levothyroxine in miscarriage and preterm delivery rates in first trimester thyroid antibody-positive women with TSH <2.5 IU/L. Journal of Clinical Endocrinology and Metabolism 2016 26 jc20161803. (doi:10.1210/ jc.2016-1803)
61. World Health Organization. Urinary iodine concentrations for determining iodine status in populations. WHO/NMH/NHD/ EPG/13.1, 2013.